CompletedNot applicableNCT01472640

The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus

Studying MODY

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Flyvbjerg, Allan, DMSc
Principal Investigator
Allan Flyvbjerg, dean
University of Aarhus
Intervention
liraglutide(drug)
Enrollment
240 target
Eligibility
30-85 years · All sexes
Timeline
20112015

Study locations (4)

Collaborators

Novo Nordisk A/S

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01472640 on ClinicalTrials.gov

Other trials for MODY

Additional recruiting or active studies for the same condition.

See all trials for MODY

← Back to all trials